Evidence map›Paper›PMID 41487768›Full record

ArticleCureus2025

Non-thyroid Malignancies With Metastases to the Thyroid Gland: A Case Series and Review of the Literature.

Anderson Okafor, Juliana Chaves de Oliveira, Moumita S Choudhury, Julie Samantray

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anderson OkaforEndocrinology and Diabetes, Wayne State University, Detroit Medical Center, Detroit, USA.
Juliana Chaves de OliveiraInternal Medicine, Wayne State University, Detroit Medical Center, Detroit, USA.
Moumita S ChoudhuryPathology, Wayne State University, Detroit Medical Center, Detroit, USA.
Julie SamantrayEndocrine Oncology, Karmanos Cancer Center, Detroit, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastasis of non-thyroid malignancies (NTMs) to the thyroid gland is an uncommon phenomenon. The most frequently reported primary tumors include renal cell carcinoma (RCC), lung cancer, colorectal cancer, breast carcinoma, and melanoma. We present a case series of four patients with tumor-to-tumor metastases involving the thyroid gland. Primary tumors included colon adenocarcinoma, clear cell RCC, and malignant melanoma. Each case was evaluated for imaging findings and clinicopathologic features, treatment, and outcomes. In all cases, the metastases occurred at a subsequent time following the primary cancer diagnosis. The average time to thyroid metastasis was 41.5 months for colorectal cancer, 68 months for RCC, and 20.9 months for melanoma. Imaging characteristics such as hypoechogenicity, irregular margins, increased vascularity, and fluorodeoxyglucose avidity were present and consistent with malignant features in all cases. Subsequent pathology analysis was essential for accurate diagnosis. Treatment consisted of hemi or total thyroidectomy in all cases, followed by thyroid hormone replacement therapy in three out of the four patients. Although rare, metastases to the thyroid gland should be considered in patients with a history of malignancy who present with suspicious thyroid nodules. This case series demonstrates the diagnostic challenges and emphasizes the importance of radiologic vigilance and confirmatory histopathology in detecting and managing thyroid metastases from non-thyroid primaries.

Indexed as

colorectal neoplasmsmelanomaneoplasm metastasisrenal cell carcinomathyroid neoplasmsthyroid noduletumor-to-tumor metastasis

Identifiers

PMID41487768
PMCPMC12764360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.